J. Trocio

发表

IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine.

J. Lisziewicz, F. Lori, D. Weiner, 2008, Vaccine.

Real-world comparison of all-cause hospitalizations, hospitalizations due to stroke and major bleeding, and costs for non-valvular atrial fibrillation patients prescribed oral anticoagulants in a US health plan

A. Amin, J. Trocio, O. Dina, 2018, Journal of medical economics.

Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States

A. Amin, J. Trocio, Jay Lin, 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Physician and Patient Preferences for Nonvalvular Atrial Fibrillation Therapies.

J. Trocio, J. Romley, J. Shafrin, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Leveraging Real-World Evidence in Disease-Management Decision-Making with a Total Cost of Care Estimator.

J. Trocio, J. Munakata, C. Ferrufino, 2016, American health & drug benefits.

Predictors of discontinuing overactive bladder medications

J. Benner, J. Trocio, L. Brubaker, 2010, BJU international.

HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.

J. Lisziewicz, F. Lori, M. G. Ferrari, 2007, Virology.

Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings

J. Trocio, O. Dina, P. Hlavacek, 2018, ClinicoEconomics and outcomes research : CEOR.

Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States

A. Amin, J. Trocio, Jay Lin, 2015, Journal of managed care & specialty pharmacy.

Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients

A. Amin, J. Trocio, Jay Lin, 2014, Journal of medical economics.

Evaluation of medical costs avoided when new oral anticoagulants are used for extended treatment of venous thromboembolism based on clinical trial results

A. Amin, J. Trocio, Jay Lin, 2015, Journal of Thrombosis and Thrombolysis.

Linguistic validation of translation of the self-assessment goal achievement (saga) questionnaire from English

J. Trocio, C. Evans, E. Piault, 2012, Health and Quality of Life Outcomes.

Abstract 19672: Comparison of Major-bleeding Risk and Health Care Costs Among Treatment-naïve Non-valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

A. Amin, O. Baser, J. Trocio, 2015 .

Abstract 17609: Comparison of All-cause and Bleeding-related Hospitalizations Among Non-valvular Atrial Fibrillation Patients Receiving Oral Anticoagulants

J. Trocio, S. Deitelzweig, K. Gupta, 2015 .

Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: A decision-tree model

J. Trocio, J. Rejas, D. Arumí, 2011, BMC urology.

Patient‐reported reasons for discontinuing overactive bladder medication

J. Benner, M. Nichol, J. Trocio, 2010, BJU international.

Control of viral rebound through therapeutic immunization with DermaVir

J. Lisziewicz, F. Lori, S. Arya, 2005, AIDS.

Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes

J. Lisziewicz, F. Lori, E. Somogyi, 2014, Gene Therapy.

DermaVir: a novel topical vaccine for HIV/AIDS.

J. Lisziewicz, F. Lori, J. Behr, 2005, The Journal of investigative dermatology.

Detecting Atrial Fibrillation in the Emergency Department in Patients with Cardiac Implantable Electronic Devices.

J. Trocio, Besa Smith, J. Mardekian, 2019, The Journal of emergency medicine.

Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation

J. Trocio, D. Leslie, Guodong Liu, 2016, Drugs - Real World Outcomes.

Economic Burden of Undiagnosed Nonvalvular Atrial Fibrillation in the United States.

Jason Shafrin, Mintu P Turakhia, Dana P Goldman, 2015, The American journal of cardiology.

All-Cause, Stroke/Systemic Embolism–, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants

J. Trocio, P. Hlavacek, Jay Lin, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Economic Evaluations of Medical Cost Differences: Use of Targeted-SpecificOral Anticoagulants vs. Warfarin among Patients with Nonvalvular AtrialFibrillation and Venous Thromboembolism in the U.S.

A. Amin, J. Trocio, Jay Lin, 2015 .

Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US

A. Amin, J. Trocio, Jay Lin, 2015, Journal of medical economics.

A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population

A. Amin, O. Baser, J. Trocio, 2018, Journal of managed care & specialty pharmacy.

Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense Population

J. Trocio, A. Nadkarni, O. Dina, 2018, Journal of managed care & specialty pharmacy.

Estimated prevalence of undiagnosed atrial fibrillation in the United States

Dana P. Goldman, Jason Shafrin, Katalin Bognar, 2018, PloS one.

Comparison of hospital length of stay and hospitalization costs among patients with non-valvular atrial fibrillation treated with apixaban or warfarin: An early view

O. Baser, J. Trocio, J. Mardekian, 2016, Journal of medical economics.

Effect of Apixaban Versus Warfarin Use on Health Care Resource Utilization and Costs Among Elderly Patients with Nonvalvular Atrial Fibrillation.

J. Trocio, Jay Lin, J. Mardekian, 2017, Journal of managed care & specialty pharmacy.

Treatment and discharge patterns among patients hospitalized with non-valvular atrial fibrillation transitioning from the inpatient to outpatient setting

J. Trocio, H. Henk, J. Mardekian, 2018, Current medical research and opinion.

Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records

J. Menzin, M. Friedman, J. Trocio, 2015, BMC Women's Health.

Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population

J. Trocio, A. Nadkarni, O. Dina, 2019, BMC Cardiovascular Disorders.

A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population

A. Amin, O. Baser, J. Trocio, 2018, Journal of managed care & specialty pharmacy.

Comparison of hospital length of stay between hospitalized non-valvular atrial fibrillation patients treated with either apixaban or warfarin

J. Trocio, A. Farr, S. Johnston, 2014, Hospital practice.

ECONOMIC BURDEN OF UNDIAGNOSED NONVALVULAR ATRIAL FIBRILLATION IN THE UNITED STATES

M. Turakhia, J. Trocio, K. Bognar, 2015 .

Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder

S. Kaplan, J. Trocio, M. Botteman, 2012, Journal of medical economics.

Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting

J. Trocio, A. Nadkarni, Jay Lin, 2017, Journal of medical economics.

Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation

J. Trocio, Jay Lin, S. Deitelzweig, 2016, Current medical research and opinion.

Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire

C. Kelleher, J. Trocio, L. Brubaker, 2011, International Urogynecology Journal.

DermaVir, a novel HIV immunisation technology.

J. Lisziewicz, F. Lori, J. Trocio, 2005, Vaccine.

Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population

A. Amin, O. Baser, J. Trocio, 2017, Current medical research and opinion.

Clinical value of a patient‐reported goal‐attainment measure: the global development of self‐assessment goal achievement (SAGA) questionnaire for patients with lower urinary tract symptoms

C. Kelleher, J. Trocio, L. Brubaker, 2014, Neurourology and urodynamics.

Validation study of the Self‐Assessment Goal Achievement (SAGA) questionnaire for lower urinary tract symptoms

L. Brubaker, C. Kelleher, J. Trocio, 2013, International journal of clinical practice.

Impact of Warfarin Persistence on Health-Care Utilization and Costs Among Patients With Atrial Fibrillation Managed in Anticoagulation Clinics in the United States

J. Trocio, Jay Lin, S. Deitelzweig, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants

J. Trocio, Jay Lin, S. Deitelzweig, 2016, Current medical research and opinion.

Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients

J. Trocio, Jay Lin, J. Mardekian, 2017, Current medical research and opinion.

Challenges for managing overactive bladder and guidance for patient support.

J. Trocio, L. Brubaker, V. Schabert, 2009, The American journal of managed care.

Fesoterodine Prescription Fill Patterns and Evaluation of the YourWay Patient Support Plan for Patients With Overactive Bladder Symptoms and Physicians

K. Zou, K. Burgio, J. Trocio, 2014, Postgraduate medicine.